410 IAC 16.2-5-12 - Infection control
Authority: IC 16-28-1-7
Affected: IC 4-21.5; IC 16-28-5-1
Sec. 12.
(a) The
facility must establish and maintain an infection control practice designed to
provide a safe, sanitary, and comfortable environment and to help prevent the
development and transmission of diseases and infection.
(b) The facility must establish an infection
control program that includes the following:
(1) A system that enables the facility to
analyze patterns of known infectious symptoms.
(2) Provides orientation and in-service
education on infection prevention and control, including universal
precautions.
(3) Offering health
information to residents, including, but not limited to, infection transmission
and immunizations.
(4) Reporting
communicable disease to public health authorities.
(c) Each resident shall have a diagnostic
chest x-ray completed no more than six (6) months prior to admission.
(d) Prior to admission, each resident shall
be required to have a health assessment, including history of significant past
or present infectious diseases and a statement that the resident shows no
evidence of tuberculosis in an infectious stage as verified upon admission and
yearly thereafter.
(e) In addition,
a tuberculin skin test shall be completed within three (3) months prior to
admission or upon admission and read at forty-eight (48) to seventy-two (72)
hours. The result shall be recorded in millimeters of induration with the date
given, date read, and by whom administered and read.
(f) For residents who have not had a
documented negative tuberculin skin test result during the preceding twelve
(12) months, the baseline tuberculin skin testing should employ the two-step
method. If the first step is negative, a second test should be performed within
one (1) to three (3) weeks after the first test. The frequency of repeat
testing will depend on the risk of infection with tuberculosis.
(g) All residents who have a positive
reaction to the tuberculin skin test shall be required to have a chest x-ray
and other physical and laboratory examinations in order to complete a
diagnosis.
(h) All skin testing for
tuberculosis shall be done using the Mantoux method (5TU, PPD) administered by
persons having documentation of training from a department-approved course of
instruction in intradermal tuberculin skin testing, reading, and
recording.
(i) Persons with a
documented history of a positive tuberculin skin test, adequate treatment for
disease, or preventive therapy for infection shall be exempt from further skin
testing. In lieu of a tuberculin skin test, these persons should have an annual
risk assessment for the development of symptoms suggestive of tuberculosis,
including, but not limited to, cough, fever, night sweats, and weight loss. If
symptoms are present, the individual shall be evaluated immediately with a
chest x-ray.
(j) When the infection
control program determines that a resident needs isolation to prevent the
spread of infection, the facility must isolate the resident only to the degree
needed to isolate the infecting organism.
(k) The facility must require staff to wash
their hands after each direct resident contact for which hand washing is
indicated by accepted professional practice.
(l) For purposes of IC
16-28-5-1,
a breach of:
(1) subsection (a) is an
offense;
(2) subsection (j) or (k)
is a deficiency; and
(3) subsection
(b), (c), (d), (e), (f), (g), (h), or (i) is a noncompliance.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.